These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6516754)

  • 1. The haemodynamic effects of labetalol, ketanserin and a placebo at the end of a NLA. A double blind study.
    Barvais L; Capouet V; d'Hollander A
    Acta Anaesthesiol Belg; 1984; 35 Suppl():453-6. PubMed ID: 6516754
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects of labetalol on the humeral artery of the hypertensive patient. A double-blind study versus placebo].
    Pithois-Merli I; Cournot AX; Georges DR; Pappo M; Safar ME
    Ann Cardiol Angeiol (Paris); 1987; 36(7):371-4. PubMed ID: 3662385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled hypotension with labetalol in lengthy otologic microsurgery (hemodynamic study)].
    Bertrand D; Bollaert PE; Laxenaire MC; Wayoff M
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1984 Nov; 33(9):461-71. PubMed ID: 6527119
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.
    Lund-Johansen P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):107S-111S. PubMed ID: 583322
    [No Abstract]   [Full Text] [Related]  

  • 5. Is ketanserin a D receptor antagonist?
    Lancet; 1983 Mar; 1(8326 Pt 1):703-4. PubMed ID: 6132056
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic study of a new injectable anti-hypertensive: labetalol].
    Clementy J; Dallocchio M
    Nouv Presse Med; 1978 Dec; 7(43):3934. PubMed ID: 733550
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of intravenous labetalol on hemodynamics and myocardial metabolism in coronary insufficiency].
    Lardoux H; Ourbak P; Pornin M; Duong TC; Chouty F; Maurice P
    Therapie; 1983; 38(2):149-54. PubMed ID: 6636022
    [No Abstract]   [Full Text] [Related]  

  • 8. Ketanserin's sympatholytic and serotonin2-receptor blocking actions precede the hypotensive effects.
    Egan BM; Stepniakowski K; Zweifler AJ
    J Hum Hypertens; 1994 Jan; 8(1):59-64. PubMed ID: 8151608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.
    Taylor SH; Silke B; Nelson GI; Okoli RC; Ahuja RC
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):325-7. PubMed ID: 6807469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 11. I.V. Labetalol during coronary artery surgery.
    Joucken K
    Acta Anaesthesiol Belg; 1983; 34(1):15-26. PubMed ID: 6845955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm.
    De Caterina R; Carpeggiani C; L'Abbate A
    Circulation; 1984 May; 69(5):889-94. PubMed ID: 6705164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endocrine and metabolic changes induced in surgery by the combination of ketanserin and alfentanyl].
    Carrasco MS; Arroyo JL; De Castro J; Sanchez G; Esteban J
    Agressologie; 1985 Jun; 26(7):605-7. PubMed ID: 2863993
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of isometric exercise and mental stress on blood pressure--comparative effects of propranolol and labetalol.
    Anand MP; Dattani KK; Datey KK
    Indian Heart J; 1984; 36(1):4-7. PubMed ID: 6706367
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind study with oral labetalol (Trandate)--a new hypotensive agent.
    Nontak MA; Ahmad S; Maheendran KK; Abdullah Z
    Singapore Med J; 1980 Feb; 21(1):474-8. PubMed ID: 6994236
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic and haemodynamic effects of increased circulating adrenaline in man. Effect of labetalol, an alpha and beta blocker.
    Struthers AD; Whitesmith R; Reid JL
    Br Heart J; 1983 Sep; 50(3):277-81. PubMed ID: 6615664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of esmolol and labetalol to attenuate haemodynamic responses after electroconvulsive therapy.
    Shrestha S; Shrestha BR; Thapa C; Pradhan SN; Thapa R; Adhikari S
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):318-23. PubMed ID: 18604047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
    Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
    Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol in mild and moderate hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1980 Sep; 224(1347):945-9. PubMed ID: 7003576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.